返回 Agenda
S3-2 - What’s new in ICH guidelines? (2)
Session Chair(s)
Myounghee Kim
Senior Director, Clinical Operations
IQVIA Korea, Korea, Republic of
Nayoung Lee, MBA
Vice president, Commercial APAC
PAREXEL, Korea, Republic of
Speaker(s)
Nan Wang, PHD
GSK, China
Head, Asia Medical Writing
Bongkyoo Choi, MPH, RPH
GC Biopharma, AI & Data Science Center, Korea, Republic of
Sr. Research Fellow/Head/Vice President, R&D Dept.
Young Su Noh, PHD
Hanmi Pharmaceuticals , Korea, Republic of
Director, Head of Clinical Research and Development